tiprankstipranks
Trending News
More News >

Brad's Holdings - New Portfolio

Lazy Brad

Brad's Holdings
Individual Investor
Ranked #266,498 out of 851,975 TipRanks' Investors
Success Rate
64%
30 out of 47
profitable transactions
Average Return
17.18%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 8.54%
6-Month Return▲ 29.02%
12-Month Return-
YTD Return▼ 8.46%
Total Return▲ 54.44%

Best Trade

Opened at
Closed at
Gain▲ 242.23%

Bio

As a serious and responsible investor, I secured my assets in a classic Lazy Portfolio, the old good 60/40. Can you imagine how boring it is? So the Mr. Hyde in me diverted some pocket $$ from it to cherry-pick this bunch of risky, volatile stocks.

Performance

13.97%0-13.97%
▲ 9.25%
▲ 5.14%
▼ 2.25%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 3.64%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 1.90%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.95%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.48%
Oct 2025
▼ 3.58%
▲ 0.19%
▲ 4.72%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 13.97%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 8.46%
Jan 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 9.25%▲ 5.14%▼ 2.25%
▲ 7.60%▲ 2.30%▼ 3.64%
▲ 2.76%▲ 2.05%▲ 1.90%
▲ 12.88%▲ 3.56%▲ 8.95%
▲ 10.96%▲ 2.38%▲ 4.48%
▼ 3.58%▲ 0.19%▲ 4.72%
▼ 0.10%▲ 0.08%▲ 13.97%
▲ 4.06%▲ 1.47%▼ 8.46%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Cidara Therapeutics
▲ 210.84%
2
Close
Jan 06, 2026
Bitdeer Technologies
▼ 28.14%
5
Close
Jan 03, 2026
KalVista Pharmaceuticals
▲ 12.05%
4
Close
Jan 03, 2026
PureCycle Technologies
▼ 2.53%
2
Close
Jan 03, 2026
Coupang
▼ 19.60%
2
Close
Jan 03, 2026
Kyndryl Holdings Incorporation
▼ 35.62%
2
Close
Jan 03, 2026
Novo Nordisk
▼ 26.39%
2
Close
Jan 03, 2026
TopBuild
▲ 47.15%
2
Close
Jan 03, 2026
Nuvation Bio
▲ 242.23%
2
Close
Jan 03, 2026
Capricor Therapeutics
▲ 85.43%
2
Close
Jan 03, 2026
RegenXBio
▲ 44.55%
2
Close
Jan 03, 2026
Ultragenyx Pharmaceutical
▼ 38.36%
2
Close
Jan 03, 2026
BioCryst
▼ 28.54%
2
Close
Jan 03, 2026
Apogee Therapeutics
▲ 101.69%
2
Close
Jan 03, 2026
Celldex
▼ 1.23%
2
Close
Jan 03, 2026
Aclaris Therapeutics
▲ 35.90%
2
Close
Jan 03, 2026
Adagio Medical Holdings
▼ 43.41%
2
Close
Jan 03, 2026
Kura Oncology
▲ 15.64%
2
Close
Jan 03, 2026
Vanda
▲ 75.28%
2
Close
Jan 03, 2026
Exelixis
▲ 5.74%
2
Close
Jan 03, 2026